[ExI] Problem with Pattents
Rafal Smigrodzki
rafal.smigrodzki at gmail.com
Tue Mar 4 01:24:52 UTC 2008
On Mon, Feb 25, 2008 at 11:16 PM, Tom Tobin <korpios at korpios.com> wrote:
> On 2/25/08, Rafal Smigrodzki <rafal.smigrodzki at gmail.com> wrote:
> > On Mon, Feb 25, 2008 at 3:44 PM, Tom Tobin <korpios at korpios.com> wrote:
> >
> > > I think we're looking at the situation the wrong way. Instead of
> "How
> > > can pharma companies recoup their R&D costs?", I'd like to ask "Is
> > > there a better way to enrich the public good regarding medicine?"
> > > Between the questionable efficacy of many medical products and a
> > > laborious FDA approval process, I don't think the current system is
> a
> > > net gain; I'd rather see slower (and, hopefully, steadier) progress
> > > (with a combination of public financing, cheap generics, and looser
> > > regulations during a "prototype" testing period). I'd also like to
> > > see *far* more emphasis placed on prevention rather than treatment;
> > > prevention is both cheaper *and* more effective. A healthy diet and
> > > exercise regimen alone is worth more than the fruit of decades of
> > > research into new drugs.
> >
> >
> > ### Yeah? How does that solve the problem of e.g. glioblastoma
> > multiforme? Healthy eating? Prevention??? lol
>
> Prevention would help knock down a whole host of easy targets that
> claim plenty of lives; when heart disease kills 268 people out of
> every 100,000 per year, tossing up an example with a 2 per 100,000
> incident rate makes me scratch my head.
### What does heart disease prevention have to do with IP?
Rafal
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.extropy.org/pipermail/extropy-chat/attachments/20080303/edd7a7b2/attachment.html>
More information about the extropy-chat
mailing list